Literature DB >> 26259099

Nationwide survey of Streptococcus pneumoniae drug resistance in the pediatric field in Japan.

Takafumi Okada1,2, Yoshitake Sato1,3, Yoshikiyo Toyonaga1,4, Hideaki Hanaki5, Keisuke Sunakawa1,6.   

Abstract

BACKGROUND: Streptococcus pneumoniae is a major causative pathogen of pneumonia in children. The Drug-Resistant Pathogen Surveillance Group in Pediatric Infectious Disease conducted a nationwide surveillance of S. pneumoniae in 2000-2001, 2004, 2007, 2010 and 2012, and investigated changes in drug resistance of S. pneumoniae.
METHODS: All strains of S. pneumoniae were isolated from clinical specimens collected from pediatric patients. The minimun inhibitory concentration was measured and the strains were classified according to the Clinical Laboratory Standards Institute criteria. The isolation rates of penicillin-intermediate resistant S. pneumoniae (PISP) and penicillin-resistant S. pneumoniae (PRSP) were compared based on seven patient factors. Logistic regression analysis was also performed.
RESULTS: The sum of the isolation rates for PISP and PRSP for each period was 64.6%, 67.0%, 56.2%, 76.9% and 49.5%, respectively. Among the patient factors, age category 1 (<3 years, ≥3 years), age category 2 (infant, toddler and preschooler, schoolchild), siblings (absence, presence), and pre-treatment with antimicrobial agents (absence, presence) were associated with significant differences in the isolation rate of PISP + PRSP. An interaction was observed between pre-treatment with antimicrobial agents and schoolchild, and the isolation rate of PISP + PRSP was higher in patients with both pre-treatment with antimicrobial agents and schoolchild.
CONCLUSION: Although some changes were observed in the rate of resistance of S. pneumoniae, an increasing trend was not observed. Both pre-treatment with antimicrobial agents and age were associated with resistance, and an interaction was observed between pre-treatment with antimicrobial agents and schoolchild.
© 2015 The Authors. Pediatrics International published by John Wiley & Sons Australia, Ltd on behalf of Japan Pediatric Society.

Entities:  

Keywords:  Streptococcus pneumoniae; interaction; pediatric infectious disease; surveillance; susceptibility

Mesh:

Substances:

Year:  2016        PMID: 26259099     DOI: 10.1111/ped.12781

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  2 in total

1.  Efficacy of educational intervention on reducing the inappropriate use of oral third-generation cephalosporins.

Authors:  Atsushi Uda; Takeshi Kimura; Sho Nishimura; Kei Ebisawa; Goh Ohji; Mari Kusuki; Mariko Yahata; Rie Izuta; Tomoyuki Sakaue; Tatsuya Nakamura; Chihiro Koike; Issei Tokimatsu; Ikuko Yano; Kentaro Iwata; Takayuki Miyara
Journal:  Infection       Date:  2019-10-11       Impact factor: 3.553

2.  Model-based approach to sampling optimization in studies of antibacterial drugs for infants and young children.

Authors:  Yuji Orito; Makoto Kakara; Akira Okada; Naomi Nagai
Journal:  Clin Transl Sci       Date:  2021-04-09       Impact factor: 4.689

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.